GGrantIndex
Sort

25,944 grants matching neurodegeneration

Molecular mechanisms of synapse development and plasticity

$569,310
Zheng Li · National Institute Of Mental Health · ZIA · FY2012 · MH

Prevention of complement and immune-mediated Lewy body dementia

$569,300
Ole Isacson · Mclean Hospital · R01 · FY2021 · AG

Development and Maintenance of Lens Transparency

$569,219
John Irwin Clark · University Of Washington · R01 · FY2007 · EY

Minocycline Immune Effects on SIV CNS Disease

$569,074
M Christine Zink · Johns Hopkins University · R01 · FY2014 · MH

Optimization and validation of quantitative birefringence microscopy for assessment of myelin pathologies associated with cognitive impairments and motor deficits in young and old aging monkey brain

$569,055
Irving J Bigio · Boston University (Charles River Campus) · R01 · FY2022 · AG

Slow Outward Currents and Learning In Aging Hippocampus

$569,055
John F Disterhoft · Northwestern University At Chicago · R37 · FY2017 · AG

Trajectories and Markers of Neurodegeneration in Fragile X Premutation Carriers

$569,039
David R Hessl · University Of California At Davis · R01 · FY2017 · MH

The role of AIF3 in neurodegeneration of Alzheimer's disease

$568,987
Yingfei Wang · Ut Southwestern Medical Center · R01 · FY2021 · AG

Brain Oxygen Metabolism and Hemodynamic Impairment in Multiple Sclerosis

$568,920
Yulin Ge · New York University School Of Medicine · R01 · FY2012 · NS

Uncovering mechanisms and developing novel therapeutic strategies for TBCD-related developmental and epileptic encephalopathy

$568,866
Allison M Bradbury · Research Inst Nationwide Children'S Hosp · R01 · FY2025 · NS

Pioneer transcription factors in aging and neurodegeneration

$568,692
Ashley E Webb · Buck Institute For Research On Aging · R01 · FY2024 · AG

Developing Neuroprotective Strategies for Tau and TDP-43 Proteinopathy in FTLD

$568,671
Brian C. Kraemer · Seattle Inst For Biomedical/Clinical Res · R01 · FY2019 · NS

Personalized functional genomics for mitochondrial encephalopathy gene discovery

$568,555
Penelope E Bonnen · Baylor College Of Medicine · R01 · FY2018 · NS

Personalized functional genomics for mitochondrial encephalopathy gene discovery

$568,555
Penelope E Bonnen · Baylor College Of Medicine · R01 · FY2017 · NS

Personalized functional genomics for mitochondrial encephalopathy gene discovery

$568,555
Penelope E Bonnen · Baylor College Of Medicine · R01 · FY2016 · NS

Personalized functional genomics for mitochondrial encephalopathy gene discovery

$568,555
Penelope E Bonnen · Baylor College Of Medicine · R01 · FY2014 · NS

Personalized functional genomics for mitochondrial encephalopathy gene discovery

$568,555
Penelope E Bonnen · Baylor College Of Medicine · R01 · FY2015 · NS

Translational addiction neurobiology

$568,361
Elliot A Stein · National Institute On Drug Abuse · ZIA · FY2017 · DA

Defining the induction and maintenance of myelin-specific tolerance in T cells and B cells using local lymph node depots

$568,324
Christopher M Jewell · Univ Of Maryland, College Park · R01 · FY2022 · AI

CNS sirtuins in radiation-induced vascular permeability and neurodegeneration

$568,186
Deedee Smart · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Molecular Mechanisms of Oxidation Resistance 1 in Parkinson's disease and Lewy Body Dementia

$568,064
Bobby Thomas · Medical University Of South Carolina · R01 · FY2024 · NS

Molecular Mechanisms of Oxidation Resistance 1 in Parkinson's disease and Lewy Body Dementia

$568,064
Bobby Thomas · Medical University Of South Carolina · R01 · FY2025 · NS

Molecular Mechanisms of Oxidation Resistance 1 in Parkinson's disease and Lewy Body Dementia

$568,064
Bobby Thomas · Medical University Of South Carolina · R01 · FY2023 · NS

Autophagon: an Autophagy-Functionalizing Gene Therapy Tool for Neurodegenerative Diseases

$568,004
Abraam M. Yakoub · University Of North Dakota · R01 · FY2022 · AG

Protection from pathological tau by activation of the ER unfolded protein response

$567,765
Brian C. Kraemer · Seattle Inst For Biomedical/Clinical Res · R01 · FY2024 · AG